Today: 30 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Microsoft stock price jumps nearly 4% — what Wall Street is watching before next week’s earnings

Microsoft stock price jumps nearly 4% — what Wall Street is watching before next week’s earnings

Microsoft shares rose 3.8% to $468.31 Friday, lifting its market value to about $3.85 trillion as the broader market stayed flat. The move came despite a lingering Microsoft 365 outage, which the company said was resolved after reports peaked at over 15,000. Investors are watching next week’s tech earnings and the Federal Reserve decision for further direction.
23 January 2026
···
Nvidia stock gains on China H200 chip order report — what moves NVDA next

Nvidia stock gains on China H200 chip order report — what moves NVDA next

Nvidia shares closed up 1.5% at $187.53 after reports that Chinese regulators told Alibaba and others to prepare orders for H200 AI chips. U.S. officials have approved H200 exports to China with strict conditions, while Beijing has signaled “in-principle” approval for major tech firms. Uncertainty remains after Chinese customs blocked earlier H200 shipments. Nvidia reports earnings Feb. 25.
23 January 2026
···
Tesla stock slips after Autopilot is dropped in U.S., Canada as robotaxi push meets earnings week

Tesla stock slips after Autopilot is dropped in U.S., Canada as robotaxi push meets earnings week

Tesla shares slipped 0.1% to $448.96 late Friday after the company dropped its standard Autopilot package for new U.S. and Canadian buyers. Starting Feb. 14, only a $99-per-month Full Self-Driving (Supervised) subscription will be offered. New vehicles now include just traffic-aware cruise control. Investors await Tesla’s Jan. 28 earnings and updates on software adoption and robotaxi progress.
23 January 2026
···
IBM stock slides in afternoon trade as investors brace for earnings and fresh security news

IBM stock slides in afternoon trade as investors brace for earnings and fresh security news

IBM shares fell 1.1% to $291.51 Friday, underperforming other tech giants as traders braced for next week’s earnings and 2026 guidance. IBM Consulting announced a new “quantum-safe” security partnership, while analysts highlighted renewed software growth and the pending $11 billion Confluent deal. The company reports Q4 results on Jan. 28.
23 January 2026
···
Boston Scientific stock (BSX) climbs as heart-rhythm rivalry and deal risk stay in play

Boston Scientific stock (BSX) climbs as heart-rhythm rivalry and deal risk stay in play

Boston Scientific shares rose about 1% to $92.20 Friday, outperforming a weaker healthcare sector as investors focused on pulsed-field ablation for atrial fibrillation. The company’s $14.5 billion deal to buy Penumbra and its upcoming Feb. 4 earnings report are drawing scrutiny. Johnson & Johnson posted $24.6 billion in quarterly sales and gave 2026 guidance, while Medtronic and Abbott shares fell.
23 January 2026
SLB stock price swings after earnings beat, dividend hike and Venezuela signals

SLB stock price swings after earnings beat, dividend hike and Venezuela signals

SLB reported Q4 adjusted earnings of 78 cents per share, beating forecasts, and raised its dividend by 3.5% to $0.295. Shares rose 0.3% to $49.47 after early gains faded. The company set 2026 revenue guidance up to $37.7 billion and plans to return over $4 billion to shareholders. CEO Olivier Le Peuch cited rising customer interest in Venezuela but said expansion depends on licenses and payment terms.
23 January 2026
···
Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM

Gilead Sciences shares rose 3.5% to $135.73 Friday, hitting new highs after Phase 3 trial data showed its Trodelvy-Keytruda combo cut the risk of disease progression or death by 35% in metastatic triple-negative breast cancer. Gilead has filed for expanded approval in the U.S. and Europe. Volume reached 8.8 million shares. A Form 144 filing showed executive Deborah Telman plans to sell up to 29,215 shares.
23 January 2026
·····
FTAI Aviation stock drops in New York trade as investors weigh CFM56 pact and fresh BTIG target hike

FTAI Aviation stock drops in New York trade as investors weigh CFM56 pact and fresh BTIG target hike

FTAI Aviation shares fell 1.2% to $289.86 Friday afternoon, following the announcement of a multi-year CFM56 engine support deal with CFM International. The agreement gives FTAI direct access to OEM parts and repairs. Analyst Andre Madrid raised his price target to $335, citing the deal’s strategic value. FTAI will report Q4 and full-year results on Feb. 25.
23 January 2026
··
Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue shares rose 0.1% to $17.77 Friday as investors await a Jan. 29 shareholder vote on its proposed sale to Kimberly-Clark. The deal would give Kenvue holders $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share. Institutional Shareholder Services recommended approval but cited litigation risks. Trading volume has surged ahead of the vote.
23 January 2026
···
Amphenol stock slips as Wall Street waits for earnings next week

Amphenol stock slips as Wall Street waits for earnings next week

Amphenol shares fell about 0.9% to $151.14 Friday afternoon as investors awaited its quarterly report due January 28. Trading volume was below average, with focus on the integration of the recently acquired CommScope connectivity business. The company expects the deal to boost adjusted profits by 2026. Broader U.S. markets were mixed, with the Dow down and S&P 500 near flat.
23 January 2026
··
PNC stock price slips as regional banks slide — bond sale and Fed week loom

PNC stock price slips as regional banks slide — bond sale and Fed week loom

PNC shares fell 1.4% to $218.91 by Friday afternoon, tracking a broader 3% drop in regional bank stocks. A filing showed PNC plans to raise $1.5 billion in subordinated notes due 2041 and $1.5 billion in senior notes due 2029. Investors are watching next week’s Federal Reserve meeting and bank guidance on net interest income. First Citizens BancShares shares dropped 8% after warning of weaker net interest income for 2026.
23 January 2026
··
USB stock falls today as bank sector slides; U.S. Bancorp bond sale and Fed week in focus

USB stock falls today as bank sector slides; U.S. Bancorp bond sale and Fed week in focus

U.S. Bancorp shares fell 1.1% to $55.58 Friday afternoon, tracking a 3% drop in the SPDR S&P Bank ETF as regional banks slid after First Citizens BancShares’ weak outlook. The lender priced $2.25 billion in fixed-to-floating senior notes this week. Investors are focused on next week’s Federal Reserve meeting and its impact on bank margins. Wells Fargo, Bank of America, and JPMorgan also declined in afternoon trading.
23 January 2026
····
Accenture stock slides in New York: traders weigh Sovereign AI deal and fresh Buy call

Accenture stock slides in New York: traders weigh Sovereign AI deal and fresh Buy call

Accenture shares fell 1.2% to $281.73 by midafternoon Friday, despite recent announcements of a major AI data center partnership with Sovereign AI and Palantir across EMEA. Berenberg initiated coverage with a buy rating and a $313 target. Investors remain uncertain about the timing of revenue from new AI projects. Accenture’s next earnings call is scheduled for March 19.
23 January 2026
·········
1 … 289 290 291 292 293 … 764

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Go toTop